Clinical Trials | October 16, 2021
Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
_256_384.jpg)
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The company plans to expand its portfolio in regulated markets aggressively
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
This product will be manufactured at Lupin’s Pithampur facility In India
More than 90,000 patients utilise the services daily
Subscribe To Our Newsletter & Stay Updated
